Home    Back

Device: transcutaneous electrical vagus nerve stimulation    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
46Malignant rheumatoid arthritis1

46. Malignant rheumatoid arthritis    [ 4,183 clinical trials,   2,538 drugs,   (DrugBank: 401 drugs),   183 drug target genes,   219 drug target pathways]
Searched query = "Malignant rheumatoid arthritis", "Rheumatoid arthritis", "Rheumatoid arthritis with vasculitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 4,183 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04037111
(ClinicalTrials.gov)		July 23, 201925/7/2019Clinical Study of Escitalopram Oxalate Combined With taVNS in Depression and Concomitant Inflammatory SymptomsClinical Study of Escitalopram Oxalate Combined With Transcutaneous Vagus Nerve Stimulation in the Treatment of Depression and Concomitant Inflammatory SymptomsMajor Depressive Disorder;Rheumatoid ArthritisDevice: Transcutaneous electrical vagus nerve stimulation;Device: Sham vagus nerve stimulation;Drug: drug treatmentXijing HospitalNULLRecruiting18 Years65 YearsAll90N/AChina